Transcript ePrescript is

ePrescript
Presentation : Bernard Wathelet - MediBRIDGE
ePrescript is …
•
an European project submitted to EC
under the eTen programme;
– Co-finance Market validation projects
– Co-finance Deployment projects
– Co-finance Support and Co-ordination
projects
The objective is
• to market validate two complementary ePrescription prototypes: ePrescribe and
eTranscript, in three European markets,
Belgium, Ireland and Poland
ePrescribe
• offers the possibility to Health Care
Professionals to compose prescriptions on-line
using an updated drug database (which can be
daily updated) as well as tools enabling drug
decision support (dosage and allergy control,
drug interactions, equivalence search) offering
at the same time access to scientific
background information and patient notices
eTranscript
• offers the prescribers, using an Electronic
Healthcare Record system and integrated
decision support and ePrescribe, the
possibility to send their prescriptions to a
secure prescription pool server, accessible
by pharmacies, who can download
prescriptions as well as give, with the
consent of the patient, feedback to the
prescriber
Different scenarios
 prescription is sent indirectly to the pharmacy
 prescription is sent directly to the pharmacy
 prescription is stored on a chip card or
memory stick
Other Objectives
• Investigate and analyze the legal framework and
issues for the full deployment of ePrescription
• Obtain user feedback on service value
• Assess, review and validate the pilot
demonstration ePrescript services through
workshops, seminars, peer review and focus
groups
• Promote and encourage active involvement of all
relevant stakeholders and particularly
prescribers, pharmacies, patients and healthcare
authorities.
Other Objectives (2)
• Identify barriers, inhibitors and obstacles for
sustainable growth of ePrescript services in Europe
• Survey existing market and identify business
evidence regarding viability, sustainability and
potential growth of ePrescript
• Contributing towards the improvement of quality of
the medicinal prescriptions as such and as part of
the process of delivering and administrating
medicinal products to patient
• Synergies with other initiatives in other EU
countries
Advantages of ePrescription
• Better protection from accidents caused by hand-written
prescriptions being misread or incomplete, leading to the
dispensing of a wrong medicinal product and/or incorrect
dose specification
• Higher professional competence and cost awareness
through access to up-to-date interactive Drug Databases
• Reducing the number of call-backs from pharmacies
regarding illegible prescriptions, potential drug
interactions, and incorrect dosages.
• Enhanced stock management
• …..
Possible Threat/hurdles towards
ePrescription
•
•
•
•
Regulatory constraints and gaps
Professional competition
Big Brother fear
Lack of an acceptable level of penetration and
use of IT in both primary and secondary care, in
ancillary services as well as by pharmacists
• Lack on agreement on semantic tags and syntax
• Security, Confidentiality and Privacy issues
• …..
Schedule-Length-Budget
•
•
•
•
Project should start in February/March 2006
Length : 18 months
Co-funding: 1,25 Mio €
12 partners :
– 4 from Belgium:
•
•
•
•
MediBRIDGE
Omegasoft Medical
Omegasoft Wallonie
Commission “Normes en matières télématique dans le secteur
des soins de santé”
– 4 from Ireland
– 4 from Poland
Thank you !
[email protected]